Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
<p>In this paper analysis of anemia correction efficacy in multiple myeloma patients was shown. Patients (n = 68) treated with epoetin alfa (recombinant erythropoietin (rEPO)) 150 IU/kg subcutaneously three times per week (no more 20 weeks) were included in the study group. Patients who did no...
Main Authors: | N. A. Romanenko, N. A. Potikhonova, K. M. Abdulkadyrov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Onkogematologiâ |
Subjects: | |
Online Access: | http://oncohematology.abvpress.ru/index.php/ongm/article/view/58 |
Similar Items
-
Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01) -
Prognostic value of a number of blood laboratory parameters in the use of erythropoiesis-stimulating agents in anemic patients with lymphoproliferative diseases
by: N A Romanenko, et al.
Published: (2013-08-01) -
Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01) -
Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01) -
Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
by: N. A. Romanenko
Published: (2014-07-01)